The fifth batch of 303 overlapping varieties released
On September 6, the Chinese Pharmaceutical Society released the "Announcement of the Fifth Batch of Excessive Duplication of Drug Reminder Information". In accordance with the screening conditions for overly duplicated generic varieties, the Chinese Pharmaceutical Society monitored and analyzed the sales of approved listed drugs during 2016-2018, forming the fifth batch of overly duplicated drug alert information directory, in which 303 varieties were included.
You May Interested In
2026-07-25
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
-
Biocytogen announces the launch of the 'Nano 100 Project' to develop fully human therapeutic nanobodies against 100+ targets
-
Wantai Biotech 20-valent pneumonia vaccine started clinical trials, how far is domestic substitution?
-
Yiming Cell 'Suspension 293XS Cell Bank' completed DMF filing with the US FDA
-
The phase III clinical study of Junshi Biologics in combination with teripulimab in the treatment of advanced triple-negative breast cancer reached the primary endpoint
-
The next bombshell: 'PD-1 + ADC', Kelun, Hengrui are going to win numbness?
-
L-Rotator Biotech completed its pre-A financing and continued to increase its investment in the CGT field
-
Hainan to promote drug import facilitation
-
Enable the 'export of EU APIcertification documents' and 'pharmaceutical export salescertificate' electronic proof
-
China to focus on building quality and efficient TCM service system in next five years
Recommend Reading
-
Yangon Cuts Palm Oil Purchase Limit to 4.1kg per Order New Policy Effective August 4
-
EPA Clears Backlog of Refinery Biofuel Waivers, Sparking Fears for Ethanol Demand
-
WACKER’s 2025 Loss Reaches €805 Million as the PACE Cost-Cutting Plan Becomes the Key Variable for 2026
-
2026 Q1 Chemical Giant Earnings: Supply Contraction, Flat Demand, Full-Scale "Defense Priority"
-
FDA Pushes New Approach to “No Artificial Colors” Claims
-
March China Titanium Dioxide Market Prices Rise
-
Both Supply and Demand Surge, Formic Acid Prices Gradually Rise
-
Acrylic Prices Soar by Over 1 Year—Short-Term at High Levels, Medium-Term Under Pressure
-
Sodium Metabisulfite: Properties, Uses, and Safety
-
Fundamental Logic and Market Sentiment Shift of Lithium Carbonate in China Price Decline